Blog

 

■ Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia

Anja Hviid Simonsen, Sanna-Kaisa Herukka, Niels Andreasen et al

Alzheimer & Dementia 2017, vol 13 (3): 274-284

http://www.alzheimersanddementia.com/article/S1552-5260(16)32963-6/fulltext

 

■ Alzheimer´s disease can be treated: Why the delay?

Harry S. Goldsmith

Surg Neurol Int. 2017; 8: 133.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523480/

 

■ Is cognitive decline measurable in preclinical Alzheimer´s disease?

Sandra Weintraub, Christopher Randolph, Lisa Bain et al

Alzheimer & Dementia 2017, vol 13 (3: 322-323

http://www.alzheimersanddementia.com/article/S1552-5260(17)30052-3/fulltext

 

■ Targeting functional decline: results from the Alzhemier´s disease multiple intervention trial

Christopher M. Callahan, Malaz A. Boustani, Arlene A. Schmid et al

Ann Intern Med. 2017 , vol 7; 166(3): 164–171.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554402/

 

■ Considering sex and gender in Alzheimer disease and other dementias

Jessica L. Podcasy, C. Neill Epperson

Dialogues Clin Neurosci. 2016 Dec; 18(4): 437–446.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5286729/

 

■ Alzheimer disease makes new blood contacts

Mario Merlini, Katerina Akassoglou

Blood. 2017, vol 129(18): 2462–2463.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418641/

 

■ Update on a patient with Alzheimer disease treated with CT Scans

Jerry M. Cuttler, Eugene R. Moore, Victor D. Hosfeld, David L. Nadolski

Dose Response. 2017 Jan-Mar; 15(1): 1559325817693167

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347268/

 

■ Neuropathology of autosomal dominant Alzheimer disease in the National Alzheimer Coordinating Center Database

John M. Ringman, Sarah Monsell, Denise W. Ng et al

J Neuropathol Exp Neurol. 2016 Mar; 75(3): 284–290

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934612/

 

■ Music therapy is a potential intervention for cognition of Alzhemier´s disease: a mini-review

Rong Fang, Shengxuan Ye, Jiangtao Huangfu, David P. Calimag

Transl Neurodegener. 2017; 6: 2.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5267457/

 

■ Diagnosing the frontal variant of Alzheimer´s disease: a clinician´s yellow brick road

Russell P. Sawyer, Federico Rodriguez-Porcel, Matthew Hagen, Rhonna Shatz, Alberto J. Espay

J Clin Mov Disord. 2017; 4: 2.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333400/

 

■ Blood-based biomarkers in Alzheimer disease: current state of the Science and a novel collaborative paradigma for advancing from Discovery to clinic

Sid E. O’Bryant, Michelle M. Mielke, Robert A. Rissman et al

the Biofluid Based Biomarker Professional Interest Area

Alzheimer & Dementia 2017, vol 13 (7): 727-738

http://www.alzheimersanddementia.com/article/S1552-5260(16)33056-4/fulltext

 

■ Association of blood lipids with Alzheimer´s disease: a comprehensive lipidomics analysis

Petroula Proitsi, Min Kim, Luke Whiley et al

Alzheimer & Dementia 2017, vol 13 (2): 140-151

http://www.alzheimersanddementia.com/article/S1552-5260(16)30022-X/fulltext

 

■ Defining imaging biomarker cut points for brain aging and Alzheimer´s disease

Clifford R. Jack Jr., Heather J. Wiste, Stephen D. Weigand et al

Alzheimer & Dementia 2017, vol 13 (3): 205-216

http://www.alzheimersanddementia.com/article/S1552-5260(16)32875-8/fulltext

 

■ Visual and ocular manifestations of Alzheimer´s disease and their use as biomarkers for diagnosis and progression

Fatimah Zara Javaid, Jonathan Brenton, Li Guo, Maria F. Cordeiro

Front Neurol. 2016; 7: 55

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4836138/

 

■ Assessing the economic burden of Alzheimer´s disease patients first diagnosed by specialists

Noam Y. Kirson, Urvi Desai, Ljubica Ristovska et al

BMC Geriatr. 2016; 16: 138.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940962/

 

■ Adaptive working memory strategy training in early Alzheimer´s disease: randomised controlled trial

J D Huntley, A Hampshire, D Bort et al

The British Journal of Psychiatry 2017: 61-66

http://bjp.rcpsych.org/content/210/1/61

 

■ Regional cerebral blood flow in mild cognitive impairment and Alzheimer´s disease measured with arterial spin labeling magnetic resonance imaging

Alba Sierra-Marcos

Int J Alzheimers Dis. 2017; 2017: 5479597

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442339/

 

■ Comparative analysis of the electroencephalogram in patients with Alzheimer’s disease, diffuse axonal injury patients and healthy controls using LORETA analysis.

Ianof, Jéssica Natuline et al.

Dement. neuropsychol., June 2017, vol.11, no.2, p.176-185

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642017000200176&lng=pt&nrm=iso&tlng=en

 

■ Type 2 diabetes mellitus in the pathophysiology of Alzheimer’s disease

Nazareth, Aparecida Marcelino de.

Dement. neuropsychol., June 2017, vol.11, no.2, p.105-113

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642017000200105&lng=pt&nrm=iso&tlng=en

 

■ Antidiabetic drugs in Alzheimer´s disease: mechanisms of action and future perspectves

D Femminella, L Bencivenga, L Petraglia et al

Journal of Diabetes Research 2017, (2017), ID 7420796, 7 pages

https://www.hindawi.com/journals/jdr/2017/7420796/

 

■ Planning ability impairments in probable Alzheimer’s disease patients: Evidence from the Tower of London test.

Satler, Corina, Guimarães, Luiza and Tomaz, Carlos

Dement. neuropsychol., June 2017, vol.11, no.2, p.137-144

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642017000200137&lng=pt&nrm=iso

 

■ Cross-cultural adaptation of the “Australian National University Alzheimer’s Disease Risk Index” for the Brazilian population

Borges, Marcus Kiiti, Jacinto, Alessandro Ferrari and Citero, Vanessa de Albuquerque

Dement. neuropsychol., June 2017, vol.11, no.2, p.162-175

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642017000200162&lng=pt&nrm=iso

 

■ Utility of the Neuropsychiatric Inventory Questionnaire (NPI-Q) in the assessment of a sample of patients with Alzheimer’s disease in Chile.

Musa, Gada et al.

Dement. neuropsychol., June 2017, vol.11, no.2, p.129-136

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642017000200129&lng=pt&nrm=iso

 

■ The association of antidepressant drug usage with cognitive impairment or dementia, incluing Alzheimer´s disease: a systematic review and meta-analysis

J Moraros, C Nwankwo, SB Pattern, D D Mousseasu

Anxiety & Depression 2017, vol 34: 217-226

http://onlinelibrary.wiley.com/doi/10.1002/da.22584/full

 

■ Early diagnosis of mild cognitive impairment and Alzheimer´s disease based on salivar latoferrin

Eva Carro, Fernando Bartolomé, Félix Bermejo-Pareja et al

Alzheimers Dement (Amst) 2017; 8: 131–138

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470603/

 

■ Longitudinal evaluation of critereia for subjective cognitive decline and preclinical Alzheimer´s disease in a memory clinic sample

Marie Eckerström, Mattias Göthlin, Sindre Rolstad et al

Alzheimers Dement (Amst) 2017; 8: 96–107.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443895/

 

■ Resting-state network dysfunction in Alzheimer´s disease: a systematic review and meta-analysis

AmanPreet Badhwar, Angela Tam, Christian Dansereau et al

Alzheimers Dement (Amst) 2017; 8: 73–85

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436069/

 

■ Choroidal thinning: Alzheimer´s disease and aging

João Paulo Cunha, Rita Proença, Arnaldo Dias-Santos et al

Alzheimers Dement (Amst) 2017; 8: 11–17

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390660/

 

■ Alzheimer disease: Scientific Breakthroughs and translational challenges

R J Caselli, T G Beach, D S Knopman, N R Graff-Radford

Mayo Clinic Proceedings 2017, vol 92 (6): 978-994

http://www.mayoclinicproceedings.org/article/S0025-6196(17)30158-1/fulltext

 

■ Sleep, cognitive impairment, and Alzheimer´s disease: a systematic review and meta-analysis

O M Bubu, M Brannick, J Mortimer et al

Sleep 2017, vol 40 (1)

https://academic.oup.com/sleep/article/2661823/Sleep-Cognitive-impairment-and-Alzheimer-s-disease

 

■ Use it or lose it! Cognitive activity as a protective factor for cognitive decline associated with Alzheimer´s disease

P Mistridis, J Mata, S Neuner-Jehle et al

Swiss Med Wkly 2017, vol 147: w14407

https://smw.ch/en/article/doi/smw.2017.14407/

 

■ Optimal nonpharmacological management of agitation in Alzheimer´s disease: challenges and solutions

José Carlos Millán-Calenti, Laura Lorenzo-López, Begoña Alonso-Búa et al

Clin Interv Aging. 2016; 11: 175–184.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769004/

 

■ Odor identification as a biomarker of preclinical AD in older adults at risk

M Lafaille-Magnan, J Poirier, P Etienne et al

Neurology 2017, vol 89: 327-335

http://www.neurology.org/content/early/2017/06/28/WNL.0000000000004159.full.pdf

 

■ Postmenopausal hormone therapy and Alzheimer disease: a prospective cohort study

B Imtiaz, M Tuppurainen, T Rikkonen et al

Neurology 2017, vol 88: 1062-1068

http://www.neurology.org/content/early/2017/02/15/WNL.0000000000003696.full.pdf+html

 

■ Dieta mediterránea y sus efectos benéficos en la prevención de la enfermedad de Alzheimer.

L Miranda, Arnoldo, Gómez-Gaete, Carolina and Mennickent, Sigrid

Rev. méd. Chile, Abr 2017, vol.145, no.4, p.501-507

http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872017000400010&lng=es&nrm=iso

 

■ Increased white matter inflammation in aging and Alzheimer´s disease brain

Raj D, Yin Z, Breur M et al

Front Mol Neurosci. 2017 Jun 30;10:20

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492660/

 

■ Transethnic genome-wide scan identifies novel Alzheimer´s disease loci

Gyungah R. Jun, Jaeyoon Chung, Jesse Mez

Alzheimer & Dementia 2017, vol 13 (7): 727-738

http://www.alzheimersanddementia.com/article/S1552-5260(17)30003-1/fulltext

 

■ Disease progression in mild dementia due to Alzheimer disease in na 18-month observational study (GERAS): the impact on costs and caregiver outcomes

Roy W. Jones, Jeremie Lebrec, Kristin Kahle-Wrobleski, et al

Dement Geriatr Cogn Dis Extra. 2017 Jan-Apr; 7(1): 87–100

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465649/

 

■ How do community-dwelling persons with Alzheimer disease fall? Falls in the FINALEX Studyy

Niko M. Perttila, Hannareeta Öhman, Timo E. Strandberg et al

Dement Geriatr Cogn Dis Extra. 2017 May-Aug; 7(2): 195–203

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498949/

 

■ Early-versus late-onset Alzheimer disease: long-term functional outcomes, nursing home placement, and risk factors for rate of progression

Carina Wattmo, Åsa K. Wallin

Dement Geriatr Cogn Dis Extra. 2017 Jan-Apr; 7(1): 172–18

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471791/

 

■ Serum amino acid profiles in normal subjects and in patients with or at risk of Alzheimer dementia

Gaetano Corso, Adriana Cristofano, Nadia Sapere et al

Dement Geriatr Cogn Dis Extra. 2017 Jan-Apr; 7(1): 143–159

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471778/

 

■ TDP-43, mixed pathologies, and clinical Alzheimer´s type dementia

B D James, R S Wilson, P A Boyle et al

Brain 2016, vol 139 (11): 2983-2993

https://academic.oup.com/brain/article/139/11/2983/2422129/TDP-43-stage-mixed-pathologies-and-clinical

 

■ Effects of ageing and Alzhemier disease no haemodynamic response function: a challenge for event-related Fmri

Davud Asemani, Hassan Morsheddost, Mahsa Alizadeh Shalchy

Healthc Technol Lett. 2017, vol 4(3): 109–114

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496466/

 

■ Alzheimer disease

Liana G. Apostolova

Continuum (Minneap Minn) 2016 Apr; 22(2 Dementia): 419–434

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390933/

 

■ Legal medical consideration of Alzhemier´s disease patients dysgraphia and cognitive dysfunction: a 6 month follow up

Emanuela Onofri, Marco Mercuri, Trevor Archer et al

Clin Interv Aging. 2016; 11: 279–284.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788358/

 

■ Big data to smart data in Alzheimer´s disease: the brain health modeling initiative

Hugo Geerts, Penny A. Dacks, Viswanath Devanarayan et al

Alzheimer & Dementia 2016, vol 12 (9): 1014-1021

http://www.alzheimersanddementia.com/article/S1552-5260(16)30246-1/fulltext

 

■ Genetic risk factors for the posterior cortical atrophy variant of Alzhemier´s

J M Schott, S J Crutch, M M Carrasquillo et al

Alzheimer & Dementia 2016, vol 12 (8): 862-871

http://www.alzheimersanddementia.com/article/S1552-5260(16)00077-7/fulltext

 

■ Electroencephalography-driven approach to prodromal Alzheimer´s disease diagnosis: from biomarker integration to network-level comprehension

Davide Vito Moretti

Clin Interv Aging. 2016; 11: 897–912

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939982/

 

■ Alzheimer´s disease risk variantes modultates endophenotypes in mild cognitive

Eva Louwersheimer, Steffen Wolfsgruber, Ana Espinosa et al

Alzheimer & Dementia 2016, vol 12 (8): 872-881

http://www.alzheimersanddementia.com/article/S1552-5260(16)00046-7/fulltext

 

■ Doença de Alzheimer: novas diretrizes para o diagnóstico

B O Nitzsche, H P de Moraes, A R Tavares Júnior

Rev Med Minas Gerais 2015, vol 25 (2): 237-243

http://www.rmmg.org/artigo/detalhes/1780

 

■ Risk fator for early psychosis in PD: insights from the Parkinson´s Progression Markers Initiative

Dominic H ffytche, Joana B Pereira, Clive Ballard et al

Neurology, Neurosurgery and Psychiatry  2017, vol 88 (84)

http://jnnp.bmj.com/content/88/4/325

 

■ Parkinson´s diseases in adults

NICE guidelines july 2017

https://www.nice.org.uk/guidance/ng71/chapter/Recommendations

 

■ Depression, anxiety, and apathy in Parkinson´s disease: insights from neuroimaging

M –C Wen, L L Chan, L C S Tan, E K Tan

European Journal of Neurology 2016, vol 23 (6)

http://onlinelibrary.wiley.com/doi/10.1111/ene.13002/full

 

■ Impulsive and compulsive behaviors in Parkinson Disease

A H Erga, G Alves, J P Larsen et al

Journal of Parkinson´s Disease 2017, vol 7 (1): 183-191

http://content.iospress.com/articles/journal-of-parkinsons-disease/jpd160977

 

■ Neuropsychological profiles in mild cognitive impairment due to Alzheimer´s and Parkinson´s diseases

E Hessen, A L Stay, E Auning et al

Journal of Parkinson´s Disease 2017, vol 6 (2): 413-421

http://content.iospress.com/articles/journal-of-parkinsons-disease/jpd150761

 

■ Validation of the National Institute of Neurological Disorders and Stroke criteria for psychosis in Parkinson Diseases

P C Gordon, M S G Rocha, R G Kauark et al

The American Journal of Geriatric Psychiatry 2017, vol 25 (1): 73-80

http://www.ajgponline.org/article/S1064-7481(16)30213-5/fulltext

 

■ Stability of mild cognitive impairment in newly diagnosed Parkinson´s disease

Rachael A Lawson, Alison J Yarnall, Gordon W Duncan et al

On behalf of the ICICLE-PD study group

Neurology, Neurosurgery and Psychiatry  2017, vol 88 (8

http://jnnp.bmj.com/content/88/8/648

 

■ Fatigue in early Parkinson´s disease: the Norwegian ParkWest study

S O Ongre, J P Larsen, O B Tysnes and K Herlofson

European Journal of Neurology 2017, vol 24 (1): 105-111

http://onlinelibrary.wiley.com/doi/10.1111/ene.13161/full

 

■ Symptoms of depression in patients with mild cognitive impairment in Parkinson’s disease

Malak, Ana Lara Soares Blum et al.

Dement. neuropsychol., June 2017, vol.11, no.2, p.145-15

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642017000200145&lng=en&nrm=iso&tlng=en

 

■ Cognitive training in Parkinson´s disease: a review of studies from 2000 t0 2014

Daniel Glizer, Penny A. MacDonald

Parkinsons Dis. 2016; 2016: 9291713

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027302/

 

■ Determinants of dyadic relationship and its psychosocial impact in patients with Parkinson´s disease and their spouses

Michaela Karlstedt, Seyed-Mohammad Fereshtehnejad, Dag Aarsland, Johan Lökk

Parkinsons Dis. 2017; 2017: 4697052.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329678/

 

■ Clinical pain and neuropsychological functioning in Parkinson´s disease: Are they related?

Gwenda Engels, Wouter D. Weeda, Annemarie M. M. Vlaar, Henry C. Weinstein, Erik J. A. Scherder

Parkinsons Dis. 2016; 2016: 8675930.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737464/

 

■ Marijuana compounds: a nonconventional approach to Parkinson´s disease therapy

Mariana Babayeva, Haregewein Assefa, Paramita Basu, Sanjeda Chumki, Zvi Loewy

Parkinsons Dis. 2016; 2016: 1279042

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5165161/

 

■ Structural neuroimaging markers of cognitive decline in Parkinson´s disease

Alexandru Hanganu, Oury Monchi

Parkinsons Dis. 2016; 2016: 3217960

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848447/

 

■ Rivastigmine as a symptomatic treatment for apathy in Parkinson´s dementia complex: new aspects for this riddle

Rita Moretti, Paola Caruso, Matteo Dal Ben

Parkinsons Dis. 2017; 2017: 6219851

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376458/

 

■ Symptoms of depression in patients with mild cognitive impairment in Parkinson’s disease

Malak, Ana Lara Soares Blum et al.

Dement. neuropsychol., June 2017, vol.11, no.2, p.145-153

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642017000200145&lng=en&nrm=iso&tlng=en

 

■ An integrated review of psychological stress in Parkinson´s disease: biological mechanisms and symptom and health outcomes

Kim Wieczorek Austin, Suzanne Weil Ameringer, Leslie Jameleh Clou

Parkinsons Dis. 2016; 2016: 9869712.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5183774/

 

■ Bipolar disorder, a precursor of Parkinson’s disease?

Novaretti, Tânia M.S., Novaretti, Nathália and Tumas, Vitor

Dement. neuropsychol., Dec 2016, vol.10, no.4, p.361-364

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642016000400361&lng=en&nrm=iso

 

■ Gait, posture and cognition in Parkinson’s disease.

Barbosa, Alessandra Ferreira et al.

Dement. neuropsychol., Dec 2016, vol.10, no.4, p.280-286

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642016000400280&lng=en&nrm=iso

 

■ Neuropsychological profile of Parkinson’s disease patients selected for deep brain stimulation surgery.

Machado, Flavia Amaral et al.

Dement. neuropsychol., Dec 2016, vol.10, no.4, p.296-302

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642016000400296&lng=en&nrm=iso

 

■ Comparison of the use of screening tools for evaluating cognitive impairment in patients with Parkinson’s disease.

Camargo, Carlos Henrique Ferreira et al.

Dement. neuropsychol., Dec 2016, vol.10, no.4, p.344-350

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642016000400344&lng=en&nrm=iso

 

■ The impact of cognitive performance on quality of life in individuals with Parkinson’s disease.

Olchik, Maira Rozenfeld et al.

Dement. neuropsychol., Dec 2016, vol.10, no.4, p.303-309

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642016000400303&lng=en&nrm=iso

 

■ Some aspects of the validity of the Montreal Cognitive Assessment (MoCA)for evaluating cognitive impairment in Brazilian patients with Parkinson’s disease

Tumas, Vitor et al.

Dement. neuropsychol., Dec 2016, vol.10, no.4, p.333-338

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642016000400333&lng=en&nrm=iso

 

■ Cluster analysis of cognitive performance in a sample of patients with Parkinson’s disease.

Souza, Carolina Pinto et al.

Dement. neuropsychol., Dec 2016, vol.10, no.4, p.315-319

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642016000400315&lng=en&nrm=iso

 

■ An integrated review of psychological stress in Parkinson´s disease: biological mechanisms and symptom and health outcomes

Kim Wieczorek Austin, Suzanne Weil Ameringer, Leslie Jameleh Cloud

Parkinsons Dis. 2016; 2016: 9869712.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5183774/

 

■ Cortical and striatal reward processing in Parkinson´s disease psychosis

Sara Garofalo, Azucena Justicia, Gonzalo Arrondo et al

Front Neurol. 2017; 8: 156

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402044/

 

■ Cerebral glucose metabolism and cognition in newly diagnosed Parkinson´s disease: ICICLE-PD study

M J Firbank, A J Yarnall, R A Lawson et al

J Maxwell, D J Brooks, D J Burn

Neurology, Neurosurgery and Psychiatry 2017, vol 88 (4)

http://jnnp.bmj.com/content/88/4/310

 

■ The treatment of sleep disorders in Parkinson´s disease: from research to clinical practice

Giuseppe Loddo, Giovanna Calandra-Buonaura, Luisa Sambati et al

Front Neurol. 2017; 8: 42.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5311042/

 

■ REM sleep behaviour disorder: prodromal and mechaistic insights for Parkinson´s disease

Neurology, Neurosurgery and Psychiatry 2017, vol 88 (5)

http://jnnp.bmj.com/content/88/5/445

 

■ Telerehabilitation in Parkinson’s disease: Influence of cognitive status.

Dias, Alice Estevo et al.

Dement. neuropsychol., Dec 2016, vol.10, no.4, p.327-332

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642016000400327&lng=en&nrm=iso